Displaying One Session

Sevilla Auditorium (Hall 2) Educational session
Date
29.09.2019
Time
14:45 - 16:15
Location
Sevilla Auditorium (Hall 2)
Chairs
  • Alessandra Curioni (Zurich, Switzerland)
  • Johan F. Vansteenkiste (Leuven, Belgium)
Immunotherapy in thoracic malignancies: What has been achieved in 2019? Educational session

Does surgery still have a role in stage III NSCLC in the era of immunotherapy? The surgeon’s view (ID 84)

Lecture Time
14:45 - 15:10
Speakers
  • Ad Verhagen (Nijmegen, Netherlands)
Location
Sevilla Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
14:45 - 16:15
Immunotherapy in thoracic malignancies: What has been achieved in 2019? Educational session

Does radiotherapy still have a role in stage III NSCLC in the era of immunotherapy? The radiotherapist’s view (ID 83)

Lecture Time
15:10 - 15:35
Speakers
  • Kevin Franks (, United States of America)
Location
Sevilla Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
14:45 - 16:15
Immunotherapy in thoracic malignancies: What has been achieved in 2019? Educational session

Where is immunotherapy for small cell lung cancer and mesothelioma now? (ID 82)

Lecture Time
15:35 - 16:00
Speakers
  • Alessandra Curioni (Zurich, Switzerland)
Location
Sevilla Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
14:45 - 16:15
Immunotherapy in thoracic malignancies: What has been achieved in 2019? Educational session

Discussion (ID 390)

Lecture Time
16:00 - 16:15
Location
Sevilla Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
14:45 - 16:15